Molecular characterization of carbapenem-insensitive Acinetobacter baumannii in Egypt

International Journal of Infectious Diseases

Volumn 22, Issue , 2014, Pages 49-54

  Al Agamy, Mohamed H ^a,b   Khalaf, Noha G ^c   Tawfick, Mahmoud M ^b   Shibl, Atef M ^a   El Kholy, Amani Aly ^d  

^a KING SAUD UNIVERSITY   (Saudi Arabia)

^b Al Azhar University   (Egypt)

^c October University for Modern Sciences and Arts   (Egypt)

^d CAIRO UNIVERSITY   (Egypt)

Author keywords

Antimicrobial resistance; Carbapenem insensitive Acinetobacter baumannii; ESBL; PCR

Indexed keywords

AMIKACIN; AMOXICILLIN; AZTREONAM; BETA LACTAMASE; CARBAPENEM; CARBAPENEMASE; CEFEPIME; CEFOTAXIME; CEFTAZIDIME; CIPROFLOXACIN; CLAVULANIC ACID; COLISTIN; IMIPENEM; ANTIINFECTIVE AGENT; CARBAPENEM DERIVATIVE;

ACINETOBACTER BAUMANNII; ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL GENE; BACTERIAL GENETICS; BACTERIUM DETECTION; BACTERIUM ISOLATE; EGYPT; GENE IDENTIFICATION; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PHENOTYPE; POLYMERASE CHAIN REACTION; UPREGULATION; ACINETOBACTER INFECTIONS; CLASSIFICATION; ENZYMOLOGY; EPIDEMIOLOGY; FEMALE; GENE EXPRESSION; GENETICS; HUMAN; ISOLATION AND PURIFICATION; MALE; METABOLISM; MICROBIAL SENSITIVITY TEST; MICROBIOLOGY; MOLECULAR EPIDEMIOLOGY; PLASMID;

ACINETOBACTER BAUMANNII; ACINETOBACTER INFECTIONS; ANTI-BACTERIAL AGENTS; BETA-LACTAM RESISTANCE; BETA-LACTAMASES; CARBAPENEMS; EGYPT; FEMALE; GENE EXPRESSION; HUMANS; MALE; MICROBIAL SENSITIVITY TESTS; MOLECULAR EPIDEMIOLOGY; PLASMIDS;

EID: 84897403459     PISSN: 12019712     EISSN: 18783511     Source Type: Journal    
DOI: 10.1016/j.ijid.2013.12.004     Document Type: Article

References (48)

1. Abbott I., Cerqueira G.M., Bhuiyan S., Peleg A.Y. Carbapenem resistance in Acinetobacter baumannii: laboratory challenges, mechanistic insights and therapeutic strategies. Expert Rev Anti Infect Ther 2013, 11:395-409.
2. Bonnin R.A., Nordmann P., Potron A., Lecuyer H., Zahar J.R., Poirel L. Carbapenem-hydrolyzing GES-type extended-spectrum beta-lactamase in Acinetobacter baumannii. Antimicrob Agents Chemother 2011, 55:349-354.
3. Bonnin R.A., Rotimi V.O., Al Hubail M., Gasiorowski E., Al Sweih N., Nordmann P., et al. Wide dissemination of GES-type carbapenemases in Acinetobacter baumannii isolates in Kuwait. Antimicrob Agents Chemother 2013, 57:183-188.
4. Bonnin R.A., Potron A., Poirel L., Lecuyer H., Neri R., Nordmann P. PER-7, an extended-spectrum beta-lactamase with increased activity toward broad-spectrum cephalosporins in Acinetobacter baumannii. Antimicrob Agents Chemother 2011, 55:2424-2427.
5. Poirel L., Nordmann P. Carbapenem resistance in Acinetobacter baumannii: mechanisms and epidemiology. Clin Microbiol Infect 2006, 12:826-836.
6. Rodríguez-Martínez J.M., Nordmann P., Ronco E., Poirel L. Extended-spectrum cephalosporinase in Acinetobacter baumannii. Antimicrob Agents Chemother 2010, 54:3484-3488.
7. Hrabák J., Stolbová M., Studentová V., Fridrichová M., Chudáčková E., Zemlickova H. NDM-1 producing Acinetobacter baumannii isolated from a patient repatriated to the Czech Republic from Egypt. Euro Surveill 2012, 17. pii: 20085.
8. Mohamed N.M., Raafat D. Phenotypic and genotypic detection of metallo-beta-lactamases in imipenem-resistant Acinetobacter baumannii isolated from a tertiary hospital in Alexandria, Egypt. Res J Microbiol 2011, 6:750-760.
9. Higgins P.G., Poirel L., Lehmann M., Nordmann P., Seifert H. OXA-143, a novel carbapenem-hydrolyzing class D β-lactamase in Acinetobacter baumannii. Antimicrob Agents Chemother 2009, 53:5035-5038.
10. Moubareck C., Brémont S., Conroy M.C., Courvalin P., Lambert T. GES-11, a novel integron-associated GES variant in Acinetobacter baumannii. Antimicrob Agents Chemother 2009, 53:3579-3581.
11. Bogaerts P., Naas T., El Garch F., Cuzon G., Deplano A., Delaire T., et al. GES extended-spectrum β-lactamases in Acinetobacter baumannii isolates in Belgium. Antimicrob Agents Chemother 2010, 54:4872-4878.
12. Al-Agamy M.H., Shibl A.M., Ali M.S., Khubnani H., Radwan H.H., Livermore D.M. Distribution of β-lactamases in carbapenem-non-susceptible Acinetobacter baumannii in Riyadh, Saudi Arabia. J Glob Antimicrob Res 2013, 10.1016/j.jgar.2013.08.004.
13. Cicek A.C., Saral A., Iraz M., Ceylan A., Duzgun A.O., Peleg A.Y., et al. OXA- and GES-type β-lactamases predominate in extensively drug-resistant Acinetobacter baumannii isolates from a Turkish University Hospital. Clin Microbiol Infect 2013 Jul 19, 10.1111/1469-0691.12338.
14. Hujer K.M., Hamza N.S., Hujer A.M., Perez F., Helfand M.S., Bethel C.R., et al. Identification of a new allelic variant of the Acinetobacter baumannii cephalosporinase, ADC-7 β-lactamase: defining a unique family of class C enzymes. Antimicrob Agents Chemother 2005, 49:2941-2948.
15. Villalón P., Valdezate S., Medina-Pascual M.J., Carrasco G., Vindel A., Saez-Nieto J.A. Epidemiology of the Acinetobacter-derived cephalosporinase, carbapenem-hydrolysing oxacillinase and metallo-β-lactamase genes, and of common insertion sequences, in epidemic clones of Acinetobacter baumannii from Spain. J Antimicrob Chemother 2013, 68:550-553.
16. Potron A., Munoz-Price L.S., Nordmann P., Cleary T., Poirel L. Genetic features of CTX-M-15-producing Acinetobacter baumannii from Haiti. Antimicrob Agents Chemother 2011, 55:5946-5948.
17. Robledo I.E., Aquino E.E., Vázquez G.J. Detection of the KPC gene in Escherichia coli, Klebsiella pneumoniae, Pseudomonas aeruginosa and Acinetobacter baumannii during a PCR-based nosocomial surveillance study in Puerto Rico. Antimicrob Agents Chemother 2011, 55:2968-2970.
18. Farajnia S., Azhari F., Alikhani M.Y., Hosseini M.K., Amir P., Sohrabi N. Prevalence of PER and VEB type extended spectrum beta lactamases among multidrug resistant Acinetobacter baumannii isolates in north-west of Iran. Iran J Basic Med Sci 2013, 16:751-755.
19. Akbari M., Niakan M., Taherikalani M., Feizabadi M.M., Azadi N.A., Soroush S., et al. Rapid identification of Iranian Acinetobacter baumannii strains by single PCR assay using blaOXA-51-like carbapenemase and evaluation of the antimicrobial resistance profiles of the isolates. Acta Microbiol Immunol Hung 2010, 57:87-94.
20. Howe R.A., Andrews J.M. BSAC standardized disc susceptibility testing method (version 11). BSAC Working Party on Susceptibility Testing. J Antimicrob Chemother 2012, 67:2783-2784.
21. Clinical and Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing: 19th informational supplement. CLSI document M100-S19. Wayne, PA: Clinical and Laboratory Standards Institute; 2009.
22. Dallenne C., Da Costa A., Decré D., Favier C., Arlet G. Development of a set of multiplex PCR assays for the detection of genes encoding important beta-lactamases in Enterobacteriaceae. J Antimicrob Chemother 2010, 65:490-495.
23. Poirel L., Walsh T.R., Cuvillier V., Nordmann P. Multiplex PCR for detection of acquired carbapenemase genes. Diagn Microbiol Infect Dis 2011, 70:119-123.
24. Woodford N., Ellington M.J., Coelho J.M., Turton J.F., Ward M.E., Brown S., et al. Multiplex PCR for genes encoding prevalent OXA carbapenemases in Acinetobacter spp. Int J Antimicrob Agents 2006, 27:351-353.
25. Segal H., Garny S., Elisha B.G. Is ISAba-1 customized for Acinetobacter?. FEMS Microbiol Lett 2005, 243:425-429.
26. Koeleman J.G., Stoof J., van der Bijl M.W., Vandenbroucke-Grauls C.M., Savelkoul P.H. Identification of epidemic strains of Acinetobacter baumannii by integrase gene PCR. J Clin Microbiol 2001, 39:8-13.
27. Ahmed S.H., Abdelwahab S.F., Hasanen A.M., Mohammed D.S. Multidrug resistant Egyptian isolates of Acinetobacter baumannii. J Am Sci 2011, 7:1013-1019.
28. Nasr R.A., Attalah M.F. Molecular epidemiology of nosocomial Acinetobacter baumannii isolates. Nature and Science 2012, 10:76-82.
29. Al-Hassan L., El Mehallawy H., Amyes S.G. Diversity in Acinetobacter baumannii isolates from paediatric cancer patients in Egypt. Clin Microbiol Infect 2013 Feb 15, 10.1111/1469-0691.12143.
30. Fouad M., Attia A.S., Tawakkol W.M., Hashem A.M. Emergence of carbapenem-resistant Acinetobacter baumannii harboring the OXA-23 carbapenemase in intensive care units of Egyptian hospitals. Int J Infect Dis 2013, 17:e1252-e1254. 10.1016/j.ijid.2013.07.012.
31. Bakour S., Touati A., Sahli F., Ameur A.A., Haouchine D., Rolain J.M. Antibiotic resistance determinants of multidrug-resistant Acinetobacter baumannii clinical isolates in Algeria. Diagn Microbiol Infect Dis 2013, 76:529-531.
32. Ben Othman A., Zribi M., Masmoudi A., Abdellatif S., Ben Lakhal S., Fendri C. Phenotypic and molecular epidemiology of Acinetobacter baumannii strains isolated in Rabta Hospital, Tunisia. Arch Inst Pasteur Tunis 2007, 84:11-19.
33. Al-Sweih N.A., Al-Hubail M., Rotimi V.O. Three distinct clones of carbapenem-resistant Acinetobacter baumannii with high diversity of carbapenemases isolated from patients in two hospitals in Kuwait. J Infect Public Health 2012, 5:102-108.
34. Nordmann P. Gram-negative bacteria with resistance to carbapenems. Med Sci (Paris) 2010, 26:950-959.
35. Kaase M., Nordmann P., Wichelhaus T.A., Gatermann S.G., Bonnin R.A., Poirel L. NDM-2 carbapenemase in Acinetobacter baumannii from Egypt. J Antimicrob Chemother 2011, 66:1260-1262.
36. Espinal P., Poirel L., Carmeli Y., Kaase M., Pal T., Nordmann P., et al. Spread of NDM-2-producing Acinetobacter baumannii in the Middle East. J Antimicrob Chemother 2013, 68:1928-1930.
37. Touati M., Diene S.M., Racherache A., Dekhil M., Djahoudi A., Rolain J.M. Emergence of blaOXA-23 and blaOXA-58 carbapenemase-encoding genes in multidrug-resistant Acinetobacter baumannii isolates from University Hospital of Annaba, Algeria. Int J Antimicrob Agents 2012, 40:89-91.
38. Higgins P.G., Dammhayn C., Hackel M., Seifert H. Global spread of carbapenem-resistant Acinetobacter baumannii. J Antimicrob Chemother 2010, 65:233-238.
39. Acosta J., Merino M., Viedma E., Poza M., Sanz F., Otero J.R., et al. Multidrug-resistant Acinetobacter baumannii harboring OXA-24 carbapenemase, Spain. Emerg Infect Dis 2011, 17:1064-1067.
40. Coelho J., Woodford N., Afzal-Shah M., Livermore D. Occurrence of OXA-58-like carbapenemases in Acinetobacter spp. collected over 10 years in three continents. Antimicrob Agents Chemother 2006, 50:756-758.
41. Metan G., Sariguzel F., Sumerkan B., Reijden T.V., Dijkshoorn L. Clonal diversity and high prevalence of OXA-58 among Acinetobacter baumannii isolates from blood cultures in a tertiary care centre in Turkey. Infect Genet Evol 2013, 14:92-97.
42. Migliavacca R., Espinal P., Principe L., Drago M., Fugazza G., Roca I., et al. Characterization of resistance mechanisms and genetic relatedness of carbapenem-resistant Acinetobacter baumannii isolated from blood, Italy. Diagn Microbiol Infect Dis 2013, 75:180-186.
43. Lopes B.S., Al-Hassan L., Amyes S.G. ISAba825 controls the expression of the chromosomal blaOXA-51-like and the plasmid borne blaOXA-58 gene in clinical isolates of Acinetobacter baumannii isolated from the USA. Clin Microbiol Infect 2012, 18:E446-E451.
44. Pagano M., Martins A.F., Machado A.B., Barin J., Barth A.L. Carbapenem-susceptible Acinetobacter baumannii carrying the ISAba1 upstream blaOXA-51-like gene in Porto Alegre, southern Brazil. Epidemiol Infect 2012, 19:1-4.
45. Pasterán F., Rapoport M., Petroni A., Faccone D., Corso A., Galas M., et al. Emergence of PER-2 and VEB-1a in Acinetobacter baumannii strains in the Americas. Antimicrob Agents Chemother 2006, 50:3222-3224.
46. Yong D., Shin J.H., Kim S., Lim Y., Yum J.H., Lee K., et al. High prevalence of PER-1 extended-spectrum beta-lactamase-producing Acinetobacter spp. in Korea. Antimicrob Agents Chemother 2003, 47:1749-1751.
47. Litake G.M., Ghole V.S., Niphadkar K.B., Joshi S.G. PER-1-type extended-spectrum beta-lactamase-producing Acinetobacter baumannii clinical isolates from India. Int J Antimicrob Agents 2009, 34:388-389.
48. Naas T., Bogaerts P., Bauraing C., Degheldre Y., Glupczynski Y., Nordmann P. Emergence of PER and VEB extended-spectrum beta-lactamases in Acinetobacter baumannii in Belgium. J Antimicrob Chemother 2006, 58:178-182.